B-Cell Lymphomas

Known as: lymphoma b-cell, cell b lymphoma, b cell lymphomas 
A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
A role for B-cell-receptor (BCR) signalling in lymphomagenesis has been inferred by studying immunoglobulin genes in human… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Circulating nucleic acids have been shown to have potential as non-invasive diagnostic markers in cancer. We therefore… (More)
  • table I
  • figure 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
We show that the microRNA miR-155 can be processed from sequences present in BIC RNA, a spliced and polyadenylated but non… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Review
2005
Review
2005
Primary cutaneous lymphomas are currently classified by the European Organization for Research and Treatment of Cancer (EORTC… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2005
Review
2005
Chromosomal translocations involving the immunoglobulin loci are a hallmark of many types of B-cell lymphoma. Other factors… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
A BSTRACT Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin… (More)
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is curable in less than 50% of patients… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND The survival of patients with diffuse large-B-cell lymphoma after chemotherapy is influenced by molecular features of… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?